Harbinger Health is pioneering the detection of early cancer and enabling foundationally new approaches to cancer screening, diagnosis, and management. They combine advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic. Their aim is to develop a low-cost, multi-cancer blood test.

Harbinger Health

Pioneering the detection of early cancer.  Harnessing AI and the biology of cancer's origin.

When they're not cranking out the data to support our quest to put the fear of cancer to rest, our data science team (with an assist from our Head of Automation) is out running all the miles! Congratulations to our Harbies who completed the Cambridge Half Marathon recently - Kyle Gowen, Jocelyn Charlton, Jackson Killian, Kade Pettie, Kristy Schlueter-Kuck, and Olga Seltser. We're proud of all that you accomplish both in and out of the office!

#HarbingerHealth #CancerInnovation #MCED #Harbies 

The leaves may be falling outside, but we're not heading for hibernation here at Harbinger - we keep growing! Welcome to our October new hires Ioannis Ladas, Romina Lenci, Charles 'Riggs' Raymond, CPA, Helen Oyinlola, Tracy W., Hawra Al-Rekabi, and Mattie Toolin. We're excited to see all that you achieve here!

Harbinger Health is proud to introduce our Belonging Initiative, which places a strong emphasis on ensuring that every member of our team feels a deep sense of belonging from the moment they join us. We consider belonging to be a fundamental and an ongoing aspect of our company culture. Moreover, we extend this sense of belonging to the accessibility of our products for our patients regardless of socio-economic status.  
 
To underscore our commitment to fostering a culture of belonging, our CEO Steve Hahn has signed the MassBio CEO Pledge, demonstrating our dedication to a more equitable and inclusive life sciences industry. Harbinger Health is excited to collaborate with MassBio and other national partners to actively listen and integrate practical initiatives that advance the cause of belonging. 

#belonging #diversityequtyinclusion #accessibilityinhealthcare #MCED #earlycancerdetection


We had a busy September! Welcome to Apple (Supawadee) Chawanthayatham, Dee Williams, Fangyan Yu, Christine Emery, Elena Goldthwait, Jennifer Zarutskie, Mehul G., and Erik Clement - we are so excited to have you on board.

🎤 "We are tackling three challenges in early screening. The first being, do the tests actually detect early stage cancer? The second big issue is clinical informativeness. We need to be able to give answers to a doctor to adequately take care of a patient. And the third issue is access. So many fell behind during Covid; we need to do a better job on cost and decentralization of care."

Our CEO Steve Hahn shared the stage today at #HLTH2023 for an important conversation on the key obstacles in early cancer detection. 

COM:HARBINGER-HEALTH

Harbinger Health